Recordati SpA 

€52.65
+€0.55+1.06% Friday 16:35

統計

當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
8.16B
市盈率
24.55
股息收益率
2.3%
股息
1.21

即將到來

股息

2.3%股息收益率
10年增長
16.53%
5年增長率
4.78%
3年增長率
3.57%
1年增長率
2.56%

收益

8Nov預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0.4
0.5
0.59
0.69
預期每股收益
N/A
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 REC.MI 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Show more...
首席執行官
Dr. Robert Koremans M.D.
員工
4300
國家
Italy
ISIN
IT0003828271

上市公司